imiquimod has been researched along with HPV Infection in 122 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (4.10) | 18.2507 |
2000's | 55 (45.08) | 29.6817 |
2010's | 47 (38.52) | 24.3611 |
2020's | 15 (12.30) | 2.80 |
Authors | Studies |
---|---|
Das, M; Jarrett, P; Kim, TY; Poppito, N | 1 |
Jonnalagadda, S; Palle, K; Reedy, M | 1 |
Aberle, SW; Berger, R; Boehm, I; Bogner, G; Ciresa-Koenig, A; Ganhoer-Schimboeck, J; Gleiss, A; Grimm, C; Hadjari, L; Heinze, G; Joura, E; Langthaler, E; Polterauer, S; Reich, O; Reinthaller, A; Trutnovsky, G; Widschwendter, A | 1 |
Bhari, N; Gupta, S; Sindhuja, T | 1 |
Boandl, A; Bogner, G; Ciresa-König, A; Holter, M; Jan, Z; Joura, EA; Kalteis, MS; Regauer, S; Reich, O; Schauer, C; Tamussino, K; Trutnovsky, G; Widschwendter, A | 1 |
Alvarez-Mendoza, C; Hurt, CN; Jones, S; Nedjai, B; Powell, N; Tristram, A | 1 |
Bevilacqua, F; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, M; Erzeneoglu, E; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Kyrgiou, M; Madić, T; Planchamp, F; Preti, M; Regauer, S; Reich, O; Stockdale, C; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
Bauman, JE; Chow, HS; Desravines, N; House, M; Hsu, CH; Mohnot, S; O'Connor, S; Rahangdale, L; Sahasrabuddhe, V; Sauter, E | 1 |
Benedetto, C; Bertero, L; Borella, F; Cassoni, P; Gallio, N; Mangherini, L; Preti, M | 1 |
Agrawal, M; Gandhi, V; Sharma, P; Sonthalia, S | 1 |
Bastida, C; Blanco, JL; Cranston, RD; Fuertes, I; Lopez-Cabezas, C; Mallolas, J; Ordi, J; Rodríguez-Carunchio, L | 1 |
Blontzos, N; Douligeris, A; Fotiou, A; Iavazzo, C; Karavioti, E; Prodromidou, A; Psomiadou, V; Vorgias, G | 1 |
Cheng, H; Han, R; Song, Y; Wu, X; Xu, Y; Zheng, H; Zhou, Q; Zhu, J; Zou, Z | 1 |
Brogden, DRL; Kontovounisios, C; Mills, SC; Pellino, G; Tekkis, P; Walsh, U | 1 |
Accorsi, GS; Antoniazzi, M; Dos Reis, R; Fonseca, BO; Fregnani, JHTG; Matsushita, GM; Pantano, NP; Possati-Resende, JC; Salcedo, MP; Santana, IVV; Schmeler, KM | 1 |
Bennardo, L; Cisale, GY; Nisticò, SP; Pentangelo, G; Provenzano, E | 1 |
Moore, S; Rady, P; Tyring, S | 1 |
Ballesteros, J; Calzavara-Pinton, P; Hercogová, J; Lynde, CW; Rotaru, M; Schöfer, H; Skerlev, M; Tatti, S | 1 |
Bryant, D; Fiander, AN; Hibbitts, S; Hurt, CN; Jones, SEF; Powell, N; Tristram, AJ | 1 |
Dressler, C; Nast, A; Werner, RN; Westfechtel, L | 1 |
DeAngelis, F; Greenwald, Z; Rampakakis, E; Rodier, C; Steben, M; Stutz, M; Thomas, R | 1 |
Laios, A; Lutchman-Singh, K; Mitsopoulos, V; Thomakos, N; Tranoulis, A | 1 |
Currado, F; Dal Conte, I; DI Benedetto, G; Mistrangelo, M; Morino, M; Testa, V; Volpatto, S | 1 |
Baker, JR; Brand, RM; Cranston, RD; Janocko, L; McGowan, I; Siegel, A | 1 |
Meinert, M; Vorbeck, CS; Østergård, S | 1 |
Boesecke, C; Kalff, JC; Pantelis, D; Rockstroh, J; Schwarze-Zander, C; Stoffels, B; Vilz, TO; Websky, MWV; Wesselmann, PC | 1 |
Khatun, A; Lotery, H; Sundaram, S | 1 |
Bennett, K; Copas, AJ; Doré, CJ; Gilson, R; Haddow, LJ; Jit, M; Lacey, C; Meadows, J; Murray, ML; Nathan, M; Soldan, K; Tetlow, M | 1 |
Corbett, A; Kermode, AG; Reddel, SW; Triplett, J | 1 |
Brinkmann, D; Christie, C; Harvey, G; Hughes, BR; Pontefract, D | 1 |
Gkegkes, ID; Iavazzo, C; Stamatiadis, AP | 1 |
Nelson, EL; Stockdale, CK | 1 |
Lopaschuk, CC | 1 |
Kofler, H; Kofler, L; Nagele, U | 1 |
Bejarano, PA; Berho, M; Boutros, M | 1 |
Chen, FP | 1 |
Baker, MG; Morgan, J; Wilson, N | 1 |
Ishikawa, O; Kato, M; Shimizu, A | 1 |
Cegielska, A; Fiedor, P; Imko-Walczuk, B; Kaszewski, S; Placek, W | 1 |
Bechtel, MA; Trout, W | 1 |
Ferrer, B; García-Patos, V; Gemigniani, F; Hernández-Losa, J | 1 |
Doble, R; Eric Blair, G; Macdonald, A; Richards, KH; Wasson, CW; Watherston, O; Wittmann, M | 1 |
de Witte, CJ; Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJ | 1 |
Dunne, EF; Introcaso, C; Park, IU | 1 |
Berends-van der Meer, DM; Bosse, T; Daemen, T; Fathers, LM; Fleuren, GJ; Hamming, IL; Hellebrekers, BW; Hollema, H; Kagie, MJ; Kenter, GG; Loof, NM; Löwik, MJ; Melief, CJ; Nijman, HW; Oostendorp, J; Oude Elberink, JH; Schreuder, HW; Stijnen, T; Stynenbosch, LF; Trimbos, JB; Valentijn, AR; van Beurden, M; van der Burg, SH; van Esch, EM; van Poelgeest, MI; Vermeij, R; Welters, MJ | 1 |
Kinoshita, K; Kitamura, T; Matsuda, H; Okai, T; Sekizawa, A; Suzuki, S; Tanaka, M | 1 |
Araujo, JP; Basso, RM; Borges, AS; Herman, M; Mira, J; Oliveira-Filho, JP; Olivo, G; Zakia, LS | 1 |
Bissery, MC; Bouillette-Marussig, M; Cools, N; De Coster, I; Depuydt, C; Goossens, H; Goubier, A; Hens, A; Hercend, T; Timmerman, B; Van Damme, P; Van Tendeloo, V | 1 |
Jakobsson, M; Kalliala, I; Louvanto, K; Nieminen, P; Paavonen, J; Riska, A; Tainio, K | 1 |
Fujita, M; Mitsuishi, T; Nishimura, M | 1 |
Biasoni, D; Catanzaro, MA; Colecchia, M; Giannatempo, P; Necchi, A; Nicolai, N; Paolini, B; Piva, L; Raggi, D; Salvioni, R; Stagni, S; Tesone, A; Torelli, T | 1 |
Blagovidov, DA; Kostinov, MP; Lipatov, IS; Pakhomov, DV; Protasov, AD; Ryzhov, AA; Shmitko, AD; Tezikov, YV; Vekhova, EV; Zhestkov, AV | 1 |
Alouini, S; Mathevet, P | 1 |
Kreuter, A | 1 |
Brunetti, G; Cozzi, R; Lo Schiavo, A; Puca, RV; Ruocco, E; Sangiuliano, S | 1 |
Aragoneses-Fraile, MH; Garrido-Ríos, AA; Garrosa, M; Martínez-García, G; Miranda-Romero, A; Sanz-Muñoz, C | 1 |
Da Silva, DM; Fahey, LM; Kast, WM; Raff, AB | 1 |
Aquilina, C; Bauhofer, A; Bouscarat, F; Dupin, N; Mougin, C; Ortonne, JP; Saiag, P | 1 |
A Gaspari, A; Rosen, T; Tyring, SK | 1 |
Burkhart, CN; Culton, DA; Morrell, DS | 1 |
Heratizadeh, A; Kapp, A; Kupsch, E; Völker, B; Werfel, T; Wichmann, K | 1 |
Beckmann, I; Blok, LJ; Heijmans-Antonissen, C; Helmerhorst, TJ; Kleinjan, A; Santegoets, LA; Terlou, A; van Beurden, M; van Seters, M | 1 |
Barton, DL; Clayton, AC; Gostout, BS; Jefferies, JA; Loprinzi, CL; McGovern, RM; Novotny, PJ; Pachman, DR; Sloan, JA | 1 |
Gormley, RH; Kovarik, CL | 1 |
He, Q; Introcaso, CE; Kovarik, CL; Rady, PL; Tyring, SK | 1 |
Grimm, C; Hefler, L; Heinze, G; Natter, C; Polterauer, S; Rahhal, J; Reinthaller, A; Speiser, P; Stary, G; Tempfer, CB | 1 |
Fox, PA | 1 |
Clad, A; Fischer, A; Westermann, C | 1 |
Chang, SD; Chou, HH; Huang, CC; Jao, MS; Jung, SM; Lai, CH; Lin, CT; Qiu, JT; Tang, YH; Wang, CJ; Wu, PJ | 1 |
Brodersen, JP; Dumke, P; Gutzmer, R; Kapp, A; Kaspari, M; Kiehl, P | 1 |
Dahl, MV | 1 |
Beutner, K; Cox, T; Douglas, J; Fife, K; Fukumoto, L; Moscicki, AB; Wiley, DJ | 1 |
Conant, M; Marini, M; Tyring, S; Van Der Meijden, W; Washenik, K | 1 |
Krumholz, BA; Travis, LB; Weinberg, JM | 1 |
Skinner, RB | 1 |
Mayeaux, EJ; Spigener, SD | 1 |
Hamza, S; Skelton, H; Smith, KJ | 1 |
Godfrey, JC; Vaughan, MC; Williams, JV | 1 |
Campagne, G; Martínez, A; Roca, M | 1 |
Hengge, UR; Meykadeh, N | 1 |
Dorn, C; Kupka, M; Petrow, W; Richter, ON; Ulrich, U; Wardelmann, E | 1 |
Chosidow, O; Dummer, R | 1 |
Dionisi, B; Inghirami, P; Lippa, P; Senatori, R | 1 |
Bernard, HU | 1 |
Belcastro, M; Flynn, DC; Miller, MR; Soisson, AP | 1 |
Arlette, JP; Trotter, MJ | 1 |
Benson, E | 1 |
Baroni, A; Rossiello, L; Ruocco, E; Ruocco, V | 1 |
Hengge, UR; Ruzicka, T | 1 |
Cavalcanti, SM; Nunes, Mde G; Oliveira, Ldo H; Ramos-e-Silva, M; Trope, BM | 1 |
Aubin, F; Drobacheff-Thiebaut, C; Laurent, R; Mougin, C; Pelletier, F; Venier, AG | 1 |
Lugones, L; Marchitelli, C; Perrotta, M; Pesce, R; Secco, G; Testa, R | 1 |
Benninghoff, B; Jablonska, S; Majewski, S; Marczak, M; Mlynarczyk, B | 1 |
Korting, H; Prinz, J; Weisenseel, P | 1 |
Delli, F; Dionyssopoulos, A; Koussidou-Eremondi, T; Mandekou-Lefaki, I; Mourellou-Tsatsou, O | 1 |
Costa, RR; de Freitas, VG; de Góis, NM; Kesselring, F; Kobata, MP; Ribalta, JC; Taha, NS | 1 |
Oster-Schmidt, C | 1 |
Bower, M; Dancey, G; Stebbing, J | 1 |
Esser, AC; Pittelkow, MR; Randle, HW | 1 |
Alarcón Romero, Ldel C; Hernández Quijano, T; Hernández Valencia, M; Illanes Aguiar, B; Salas Linares, N | 1 |
Berencsi, G; Melles, M; Sziller, I | 1 |
Altmeyer, P; Brockmeyer, NH; Hochdorfer, B; Kreuter, A; Pfister, H; Stücker, M; Swoboda, J; Weissenborn, SJ; Wieland, U | 1 |
Chan, CC; Chan, YC; Liao, YH; Thong, HY | 1 |
Baldauf, JJ; Baulon, E; Nisand, I; Rodriguez, B; Vautravers, A | 1 |
Bruchim, I; Ferenczy, A; Gotlieb, WH; Grzywacz, K; Mahmud, S; Tunitsky, E | 1 |
Altmeyer, P; Brockmeyer, NH; Gambichler, T; Kreuter, A; Pfister, H; Potthoff, A; Racz, P; Tenner-Racz, K; Wieland, U | 1 |
Correa, LA; He, Q; Herrera, S; Rady, PL; Sanclemente, G; Tyring, SK; Wolff, JC; Zuleta, JJ | 1 |
Nafz, J; Nindl, I; Ohnesorge, M; Rösl, F; Stockfleth, E | 1 |
Allam, JP; Appel, TR; Bieber, T; Erdsach, T; Novak, N; Wenghoefer, M | 1 |
Dommergues, C; Quinet, B | 1 |
Aaronson, NK; Beckmann, I; Burger, MP; Eijkemans, MJ; Ewing, PC; Heijmans-Antonissen, C; Helmerhorst, TJ; Kagie, MJ; Kleinjan, A; Meijer, CJ; ten Kate, FJ; van Beurden, M; van Seters, M; Zijlstra, FJ | 1 |
Apgar, BS | 1 |
Beutner, KR; Ferenczy, A | 1 |
Gross, G | 2 |
Ahmad, SA; Ahmad, SH; Ahmadpour, OA; Syed, TA | 1 |
Arndt, R; Christophers, E; Meyer, T; Röwert, J; Stockfleth, E | 1 |
Luger, T; Metze, D; Wigbels, B | 1 |
Gall, SA | 1 |
Berman, B | 1 |
Miller, R | 1 |
37 review(s) available for imiquimod and HPV Infection
Article | Year |
---|---|
Asian guidelines for condyloma acuminatum.
Topics: Adult; Antiviral Agents; Child; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomavirus Infections; Papillomavirus Vaccines | 2022 |
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus state
Topics: Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Papillomavirus Infections; Pregnancy; Quality of Life; Retrospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2023 |
Recent advances in treating female genital human papillomavirus related neoplasms with topical imiquimod.
Topics: Adjuvants, Immunologic; Female; Human Papillomavirus Viruses; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Vagina; Vulvar Neoplasms | 2023 |
Successful nonsurgical treatment of penile Buschke-Löwenstein tumor with 12 weeks of 5% imiquimod alone.
Topics: Adult; Antineoplastic Agents; Buschke-Lowenstein Tumor; Humans; Imiquimod; Interferon Inducers; Male; Ointments; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Treatment Outcome | 2019 |
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
Topics: Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; HIV Infections; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections | 2021 |
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
Topics: Acitretin; Cidofovir; Epidermodysplasia Verruciformis; HIV Infections; Humans; Imiquimod; Mycophenolic Acid; Papillomaviridae; Papillomavirus Infections; Vaccines | 2022 |
Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Catechin; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Male; Papillomavirus Infections; Plant Extracts; Tea; Treatment Outcome | 2017 |
Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
Topics: Aminoquinolines; Antiviral Agents; Anus Diseases; Coinfection; Female; Genital Diseases, Female; Genital Diseases, Male; HIV Seropositivity; Humans; Imiquimod; Immunocompetence; Male; Neoplasm Recurrence, Local; Papillomavirus Infections; Randomized Controlled Trials as Topic; Warts | 2017 |
Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia-A systematic review of the literature and a meta-analysis.
Topics: Administration, Intravaginal; Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Papillomavirus Infections; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Uterine Cervical Dysplasia; Vaginal Neoplasms; Young Adult | 2017 |
Current treatments for anal condylomata acuminata.
Topics: Aminoquinolines; Antiviral Agents; Anus Diseases; Condylomata Acuminata; Cryotherapy; Cytotoxins; Electrosurgery; Female; Humans; Imiquimod; Immunologic Factors; Interferons; Laser Therapy; Male; Papillomaviridae; Papillomavirus Infections; Photochemotherapy; Podophyllotoxin | 2018 |
[Vulvar intraepithelial neoplasia].
Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Immunocompromised Host; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Precancerous Conditions; Vulvar Neoplasms | 2018 |
Intra-anal use of imiquimod: what is the clinical evidence?
Topics: Administration, Rectal; Adult; Anal Canal; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Squamous Intraepithelial Lesions; Treatment Outcome; Warts | 2019 |
New approach to managing genital warts.
Topics: Aminoquinolines; Clinical Protocols; Condylomata Acuminata; Female; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Uterine Cervical Neoplasms | 2013 |
Anal squamous intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Photochemotherapy; Watchful Waiting | 2013 |
Sexually transmitted diseases.
Topics: Acyclovir; Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chancre; Condylomata Acuminata; Female; Herpes Genitalis; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Penicillins; Podophyllotoxin; Sexually Transmitted Diseases; Syphilis, Cutaneous; Uterine Cervical Neoplasms; Valacyclovir; Valine | 2015 |
Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2015 |
Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Topics: Adolescent; Aminoquinolines; Antiviral Agents; Anus Neoplasms; Centers for Disease Control and Prevention, U.S.; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomavirus Infections; Papillomavirus Vaccines; Practice Guidelines as Topic; Prevalence; United States; Young Adult | 2015 |
Beyond a decade of 5% imiquimod topical therapy.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Keratosis, Actinic; Papillomavirus Infections; Skin Diseases; Skin Neoplasms; Toll-Like Receptor 7 | 2009 |
The management of condyloma acuminata in the pediatric population.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cimetidine; Condylomata Acuminata; Cryotherapy; Cytosine; Dermatologic Surgical Procedures; Female; Histamine H2 Antagonists; Humans; Imiquimod; Keratolytic Agents; Laser Therapy; Lasers, Dye; Lasers, Gas; Male; Organophosphonates; Papillomavirus Infections; Podophyllotoxin; Skin; Treatment Outcome | 2009 |
[Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Biopsy; Consanguinity; DNA Probes, HPV; Drug Administration Schedule; Drug Eruptions; Epidermodysplasia Verruciformis; Facial Dermatoses; Humans; Imiquimod; Male; Oligonucleotide Array Sequence Analysis; Papillomavirus Infections; Skin | 2010 |
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts | 2012 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cidofovir; Comorbidity; Cytosine; Female; Fluorouracil; Global Health; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Incidence; Male; Organophosphonates; Papillomavirus Infections; Precancerous Conditions; Trichloroacetic Acid | 2012 |
Imiquimod; an international update on therapeutic uses in dermatology.
Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma; Condylomata Acuminata; Dermatologic Agents; DNA Virus Infections; Humans; Imiquimod; Immunocompromised Host; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms | 2002 |
Imiquimod.
Topics: Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Humans; Imiquimod; Papillomavirus Infections; Randomized Controlled Trials as Topic; Skin Diseases, Infectious | 2003 |
The imidazoquinolines and their place in the therapy of cutaneous disease.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms | 2003 |
Successful treatment of bowenoid papulosis in a 9-year-old girl with vertically acquired human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aminoquinolines; Antineoplastic Agents, Phytogenic; Bowen's Disease; Child; Female; Humans; Imiquimod; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Papillomaviridae; Papillomavirus Infections; Perineum; Podophyllin; Pregnancy; Pregnancy Complications, Infectious; Remission Induction; Skin Neoplasms; Tumor Virus Infections; Vulvar Neoplasms | 2003 |
Bowenoid papulosis of the vulva-immunotherapeutical approach with topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Diabetes Mellitus, Type 1; Female; Humans; Imiquimod; Immunotherapy; Papillomaviridae; Papillomavirus Infections; Vulvar Neoplasms | 2003 |
Imiquimod: mode of action and therapeutic potential.
Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immune System; Papillomaviridae; Papillomavirus Infections; Skin Diseases; Skin Neoplasms | 2003 |
Established and potential strategies against papillomavirus infections.
Topics: Aminoquinolines; Antimetabolites; Antiviral Agents; Cidofovir; Cytosine; Drug Design; Fluorouracil; Humans; Imiquimod; Indoles; Interferon Inducers; Interferons; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Podophyllin; Viral Vaccines | 2004 |
Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.
Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Imiquimod; Male; Papillomavirus Infections; Skin; Skin Neoplasms; Ultraviolet Rays | 2004 |
Topical immunomodulation in dermatology: potential of toll-like receptor agonists.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Humans; Imiquimod; Membrane Glycoproteins; Papillomavirus Infections; Receptors, Cell Surface; Skin Diseases, Viral; Toll-Like Receptors; Tumor Virus Infections | 2004 |
[Prevention of malignant tumors caused by human papilloma virus (HPV) by vaccination and with the methods of classical gynecologic diagnostics].
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Antineoplastic Agents; Biopsy; Cell Transformation, Neoplastic; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Male; Papanicolaou Test; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Vaginal Smears; Viral Vaccines | 2006 |
[Imiquimod and immune response modifiers in gynaecology].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Dysplasia | 2007 |
Therapeutic approaches to genital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites; Antiviral Agents; Condylomata Acuminata; Cryotherapy; Drug Therapy, Combination; Electrosurgery; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferons; Keratolytic Agents; Laser Therapy; Papillomaviridae; Papillomavirus Infections; Podophyllin; Podophyllotoxin; Tumor Virus Infections | 1997 |
Therapy of human papillomavirus infection and associated epithelial tumors.
Topics: Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Humans; Imiquimod; Interferon Inducers; Interferons; Laser Therapy; Neoplasms, Glandular and Epithelial; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Vaccines, Synthetic | 1997 |
[Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Caustics; Child; Child, Preschool; Condylomata Acuminata; Controlled Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Electrosurgery; Female; Humans; Imiquimod; Injections, Intralesional; Interferon Inducers; Interferons; Keratolytic Agents; Male; Ointments; Papillomaviridae; Papillomavirus Infections; Podophyllotoxin; Time Factors; Trichloroacetic Acid; Tumor Virus Infections | 2001 |
Female genital warts: global trends and treatments.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Global Health; Health Knowledge, Attitudes, Practice; Humans; Imiquimod; Incidence; Papillomavirus Infections; Prevalence; Risk Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2001 |
17 trial(s) available for imiquimod and HPV Infection
Article | Year |
---|---|
Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Topics: Colposcopy; Conization; Female; Humans; Imiquimod; Papillomavirus Infections; Pregnancy; Squamous Intraepithelial Lesions; Uterine Cervical Neoplasms | 2022 |
Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.
Topics: Female; Humans; Imiquimod; Lactation; Papillomavirus Infections; Pregnancy; Squamous Intraepithelial Lesions; Vulvar Neoplasms | 2022 |
Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia.
Topics: Aminoquinolines; Biomarkers; Cidofovir; DNA Methylation; Female; Human papillomavirus 16; Humans; Imiquimod; Papillomavirus Infections; Prospective Studies; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2022 |
Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Combined Modality Therapy; Electrosurgery; Female; Humans; Imiquimod; Intention to Treat Analysis; Margins of Excision; Middle Aged; Neoplasm Grading; Papillomavirus Infections; Squamous Intraepithelial Lesions of the Cervix; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2021 |
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurr
Topics: Adult; Drug Therapy, Combination; Female; Host-Pathogen Interactions; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Recurrence; Treatment Outcome; Vaccination | 2018 |
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.
Topics: Adult; Aged; Aminoquinolines; Cancer Vaccines; Carcinoma in Situ; CD8-Positive T-Lymphocytes; Female; Human papillomavirus 16; Humans; Imiquimod; Interferon-gamma; Middle Aged; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Papillomavirus Vaccines; Uterine Cervical Neoplasms; Vaccination; Vaginal Neoplasms; Vulvar Neoplasms; Young Adult | 2016 |
GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Cervix Uteri; DNA-Binding Proteins; Double-Blind Method; Female; Human papillomavirus 16; Human papillomavirus 18; Humans; Imiquimod; Middle Aged; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Papillomavirus Vaccines; T-Lymphocytes; Uterine Cervical Neoplasms; Vaccination; Viral Load; Young Adult | 2016 |
Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management.
Topics: Administration, Intravaginal; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Papillomavirus Infections; Pilot Projects; Prospective Studies; Vaginal Neoplasms; Watchful Waiting | 2016 |
Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Diseases; Condylomata Acuminata; Drug Administration Schedule; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Male; Middle Aged; Papillomavirus Infections; Treatment Outcome; Young Adult | 2009 |
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Condylomata Acuminata; Drug Administration Routes; Female; Humans; Imiquimod; Papillomavirus Infections; Severity of Illness Index; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2012 |
Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Papillomavirus Infections; Remission Induction; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Viral Load; Young Adult | 2012 |
[Effects of imiquimod on latent human papillomavirus anal infection in HIV-infected patients].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminoquinolines; Anus Diseases; Anus Neoplasms; Carcinoma; Double-Blind Method; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Papillomavirus Infections; Prospective Studies; Risk Factors | 2004 |
Treatment of bowenoid and basaloid vulvar intraepithelial neoplasia 2/3 with imiquimod 5% cream.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Papillomavirus Infections; Treatment Outcome; Vulvar Neoplasms | 2004 |
Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.
Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; DNA, Viral; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Polymerase Chain Reaction; Prospective Studies; Suppositories; Treatment Outcome | 2006 |
Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Anus Diseases; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; Genital Diseases, Male; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Treatment Outcome; Viral Load | 2007 |
Treatment of vulvar intraepithelial neoplasia with topical imiquimod.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma in Situ; DNA, Viral; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Quality of Life; Vulvar Neoplasms | 2008 |
Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Ointments; Papillomaviridae; Papillomavirus Infections; Placebos; Recurrence; Remission Induction; Tumor Virus Infections; Vulvar Diseases | 1998 |
68 other study(ies) available for imiquimod and HPV Infection
Article | Year |
---|---|
Immunotherapy for the treatment of penile intraepithelial neoplasia associated with human papilloma virus type 16 using topical imiquimod and human papilloma virus vaccination.
Topics: Aged; Human papillomavirus 16; Humans; Imiquimod; Male; Middle Aged; Papillomavirus Infections; Papillomavirus Vaccines; Penile Neoplasms; Skin Neoplasms | 2021 |
Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients.
Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections; Salvage Therapy; Toll-Like Receptor 7 | 2021 |
Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Topics: Adult; Feasibility Studies; Female; Fluorouracil; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2023 |
The effectiveness and tolerability of imiquimod suppositories to treat extensive intra-anal high-grade squamous intraepithelial lesions/warts in HIV-infected individuals.
Topics: Adjuvants, Immunologic; Administration, Rectal; Anal Canal; Anus Neoplasms; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Squamous Intraepithelial Lesions; Suppositories; Treatment Outcome; Warts | 2019 |
An Alternative Treatment for Vaginal Cuff Wart: a Case Report.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; beta-Glucans; Colposcopy; Condylomata Acuminata; Curcumin; Drug Combinations; Fatty Alcohols; Female; Humans; Imiquimod; Lactic Acid; Middle Aged; Papanicolaou Test; Papillomavirus Infections; Phyllanthus emblica; Phytotherapy; Plant Preparations; Squamous Intraepithelial Lesions of the Cervix; Vaginal Creams, Foams, and Jellies; Vaginal Diseases; Vaginal Smears | 2020 |
HPV11E7 inhibits IMQ-induced chemokine and colony-stimulating factor production in keratinocytes.
Topics: Chemokines; Colony-Stimulating Factors; Cytokines; Gene Expression; Human papillomavirus 11; Humans; Imiquimod; Keratinocytes; Mitogen-Activated Protein Kinases; Oncogene Proteins, Viral; Papillomavirus Infections; Phosphorylation; Signal Transduction | 2020 |
Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Humans; Imiquimod; Lip; Neoplasm Recurrence, Local; Papillomavirus Infections | 2021 |
Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3.
Topics: Aminoquinolines; Biomarkers; Carcinoma in Situ; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Drug Therapy, Combination; Female; Genes, Viral; Humans; Imiquimod; Neoplasm Staging; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Promoter Regions, Genetic; ROC Curve; Treatment Outcome; Vulvar Neoplasms | 2017 |
Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montréal, Canada.
Topics: Administration, Topical; Adult; Aminoquinolines; Canada; Condylomata Acuminata; Cryotherapy; Female; Health Knowledge, Attitudes, Practice; Human papillomavirus 6; Humans; Imiquimod; Male; Papillomavirus Infections; Prevalence; Recurrence; Retrospective Studies; Unsafe Sex; Young Adult | 2017 |
A Pilot Study of the Immunologic, Virologic, and Pathologic Consequences of Intra-anal 5% Imiquimod in HIV-1-Infected Men With High-Grade Squamous Intraepithelial Lesions.
Topics: Adult; Aminoquinolines; Anal Canal; Anus Neoplasms; Carcinoma in Situ; Cytokines; HIV Infections; HIV-1; Humans; Imiquimod; Male; Papillomavirus Infections; Pilot Projects; Prospective Studies | 2018 |
[Treatment of HPV-associated Anal Lesions in HIV-positive Patients - Comparison of Surgical Treatment and Topical Therapy with Imiquimod].
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; HIV; HIV Infections; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Retrospective Studies | 2019 |
Successful treatment of high-grade vulval intra-epithelial neoplasia with imiquimod 5% in a renal transplant recipient.
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Immunosuppression Therapy; Kidney; Kidney Transplantation; Middle Aged; Ointments; Papillomaviridae; Papillomavirus Infections; Transplant Recipients; Treatment Outcome; Tumor Virus Infections; Vulva; Vulvar Neoplasms | 2019 |
Warts and all: Fingolimod and unusual HPV-associated lesions.
Topics: Ankle; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Cryotherapy; Fingers; Fingolimod Hydrochloride; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunosuppressive Agents; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Warts | 2019 |
Impact of smoking on imiquimod response in patients with vulval intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Papillomavirus Infections; Retrospective Studies; Smoking; Treatment Outcome; Vulvar Neoplasms | 2019 |
Vulvar and vaginal HPV disease.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colposcopy; Condylomata Acuminata; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Interferon Inducers; Middle Aged; Neoplasm Recurrence, Local; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Trichloroacetic Acid; Vaginal Diseases; Vaginal Neoplasms; Vaginal Smears; Vulvar Diseases; Vulvar Neoplasms; Young Adult | 2013 |
Recurrent vulvovaginal candidiasis: successful suppression with imiquimod.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Candidiasis, Vulvovaginal; Female; Humans; Imiquimod; Papillomavirus Infections; Recurrence | 2013 |
Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
Topics: Aminoquinolines; Antineoplastic Agents; Cervix Uteri; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Papanicolaou Test; Papillomavirus Infections; Retrospective Studies; Severity of Illness Index; Time Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vagina; Vaginal Neoplasms; Vaginal Smears | 2013 |
Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand.
Topics: Adjuvants, Immunologic; Aminoquinolines; Child; Condylomata Acuminata; Drug Prescriptions; Female; Humans; Imiquimod; New Zealand; Papillomavirus Infections; Papillomavirus Vaccines; Pharmacies; Podophyllotoxin; Program Evaluation; Treatment Outcome; Vaccination | 2014 |
Bowenoid papulosis successfully treated with imiquimod 5% cream.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Female; Human papillomavirus 16; Humans; Imiquimod; Papillomavirus Infections; Skin Diseases, Viral; Vulvar Diseases; Young Adult | 2014 |
Human papillomavirus-related verrucous carcinoma in a renal transplant patient after long-term immunosuppression: a case report.
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Verrucous; Foot Diseases; Humans; Imiquimod; Immunocompromised Host; Immunosuppression Therapy; Kidney Transplantation; Male; Papillomavirus Infections; Skin Neoplasms | 2014 |
Focal epithelial hyperplasia by human papillomavirus (HPV)-32 misdiagnosed as HPV-16 and treated with combination of retinoids, imiquimod and quadrivalent HPV vaccine.
Topics: Adjuvants, Immunologic; Aminoquinolines; Child; Combined Modality Therapy; Diagnostic Errors; Female; Focal Epithelial Hyperplasia; Human papillomavirus 16; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Retinoids | 2015 |
The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes.
Topics: Aminoquinolines; Gene Expression Regulation, Viral; Humans; Imiquimod; Immunity, Innate; Inflammation; Keratinocytes; NF-kappa B; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Primary Cell Culture; Repressor Proteins; Toll-Like Receptor 7 | 2015 |
Current Status of Condylomata Acuminata in Pregnant Japanese Women.
Topics: Adolescent; Adult; Age Factors; Aminoquinolines; Cesarean Section; Condylomata Acuminata; Disease Management; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Interferon Inducers; Japan; Papillomavirus Infections; Practice Guidelines as Topic; Pregnancy; Prevalence; Respiratory Tract Infections | 2016 |
Imiquimod treatment for Equus caballus papillomavirus infection in equine aural plaques.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Case-Control Studies; Ear Auricle; Ear Diseases; Horse Diseases; Horses; Imiquimod; Papillomaviridae; Papillomavirus Infections; Skin Diseases, Viral | 2016 |
Topical 5% imiquimod eliminated human papillomavirus 16-associated Bowen's disease.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Biopsy; Bowen's Disease; Fingers; Human papillomavirus 16; Humans; Imiquimod; Male; Papillomavirus Infections; Skin Neoplasms | 2017 |
Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Disease-Free Survival; Humans; Imiquimod; Lasers, Gas; Male; Middle Aged; Papillomavirus Infections; Penile Neoplasms; Survival Analysis; Treatment Outcome | 2017 |
[Anogenital warts: a new way of solving the common problem of urology (results of long-term follow-up)].
Topics: Acetic Acid; Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Diseases; Combined Modality Therapy; Condylomata Acuminata; Copper; Dermatologic Agents; Female; Follow-Up Studies; Humans; Imiquimod; Lactates; Male; Nitrates; Ointments; Papillomavirus Infections; Papillomavirus Vaccines; Vaccines, Synthetic; Young Adult | 2016 |
Imiquimod for vulvar intraepithelial neoplasia.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Chemotherapy, Adjuvant; Female; Humans; Imiquimod; Papillomavirus Infections; Secondary Prevention; Vulvar Neoplasms | 2008 |
Imiquimod for vulvar intraepithelial neoplasia.
Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Viral Load; Vulvar Neoplasms | 2008 |
Contact pemphigus: a side-effect of imiquimod therapy.
Topics: Administration, Topical; Aminoquinolines; Azathioprine; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Direct; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Methylprednisolone; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pemphigus; Prednisone; Risk Assessment; Treatment Outcome; Vulvar Diseases | 2008 |
Human papillomavirus detection in multiple large-cell acanthomas.
Topics: Acanthoma; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; DNA, Viral; Female; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction | 2009 |
Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Cells, Cultured; Epitopes, T-Lymphocyte; Female; Human papillomavirus 16; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunosuppressive Agents; Langerhans Cells; Papillomavirus Infections; Quinolines; T-Lymphocytes; Toll-Like Receptor 7; Toll-Like Receptor 8; Uterine Cervical Neoplasms | 2009 |
Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p16; DNA, Viral; Female; Humans; Imiquimod; Immunoenzyme Techniques; Lymphocyte Count; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Prognosis; Vulvar Neoplasms; Young Adult | 2010 |
Human papillomavirus type 73 associated with multiple cutaneous squamous cell carcinomas in an immunosuppressed patient.
Topics: Adult; Aminoquinolines; Amputation, Surgical; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA, Viral; Fingers; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Lip Neoplasms; Male; Mohs Surgery; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin Neoplasms | 2012 |
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts | 2012 |
Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Human papillomavirus 16; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papillomavirus Infections; Remission Induction; Retrospective Studies; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms | 2013 |
Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma in Situ; DNA, Viral; Female; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Retrospective Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2012 |
Imiquimod 5% cream in the treatment of human papillomavirus-16-positive erythroplasia of Queyrat.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Erythroplasia; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Penis; Tumor Virus Infections | 2002 |
Imiquimod: a cytokine inducer.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Cytokines; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Papillomavirus Infections; Skin Diseases; Skin Diseases, Viral; Tumor Virus Infections; Warts | 2002 |
External genital warts: diagnosis, treatment, and prevention.
Topics: Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Cryotherapy; Education; Electrosurgery; Female; Floxuridine; Humans; Imiquimod; Interferons; Laser Therapy; Male; Papillomaviridae; Papillomavirus Infections; Podophyllin; Podophyllotoxin; Tumor Virus Infections | 2002 |
Successful treatment of vulvar intraepithelial neoplasia with topical imiquimod 5% cream in a lung transplanted patient.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Treatment Outcome; Tumor Virus Infections; Vulvar Neoplasms | 2002 |
Treatment of human genital papillomavirus infections.
Topics: Aminoquinolines; Antineoplastic Agents; Caustics; Cryotherapy; Electrosurgery; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Laser Therapy; Male; Papillomaviridae; Papillomavirus Infections; Podophyllin; Tumor Virus Infections | 1997 |
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms | 2003 |
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |
[Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Condylomata Acuminata; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Middle Aged; Papillomavirus Infections; Vaginal Creams, Foams, and Jellies | 2003 |
C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
Topics: Aminoquinolines; Antineoplastic Agents; CCAAT-Enhancer-Binding Protein-beta; DNA, Viral; Female; Gene Expression Regulation, Viral; HeLa Cells; Humans; Imiquimod; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Repressor Proteins; RNA, Messenger; Tumor Virus Infections; Uterine Cervical Neoplasms | 2004 |
Imiquimod: potential risk of an immunostimulant.
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Drug Antagonism; Female; Humans; Imiquimod; Immunosuppressive Agents; Papillomaviridae; Papillomavirus Infections; Recurrence; Skin Diseases; Spondylitis; Uterine Cervical Dysplasia; Vulvar Diseases; Warts | 2004 |
Imiquimod contact pemphigus: a comment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Clobetasol; Contraceptives, Oral; Female; Humans; Imiquimod; Papillomavirus Infections; Pemphigus; Treatment Outcome; Vulvar Diseases; Vulvar Neoplasms | 2004 |
Bowenoid papulosis in a patient with AIDS treated with imiquimod: case report.
Topics: Acquired Immunodeficiency Syndrome; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Humans; Imiquimod; Male; Middle Aged; Papillomavirus Infections; Penis; Scrotum; Skin Neoplasms | 2004 |
Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis.
Topics: Adjuvants, Immunologic; Aminoquinolines; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bowen's Disease; Cell Line, Tumor; Disease Models, Animal; Humans; Imiquimod; Interferon-alpha; Interleukin-18; Keratinocytes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Papillomaviridae; Papillomavirus Infections; Sarcoma; Skin Neoplasms; Tumor Necrosis Factor-alpha | 2005 |
[Treatment of paraungual HPV73-positive Bowen disease with imiquimod cream].
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Nail Diseases; Occlusive Dressings; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin; Skin Neoplasms | 2006 |
Imiquimod 5% cream: a new treatment for Bowen's disease.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Biopsy; Bowen's Disease; Carcinoma, Squamous Cell; Epidermis; Female; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms; Time Factors; Treatment Outcome | 2005 |
Grade 3 vulvar and anal intraepithelial neoplasia in a HIV seropositive child--therapeutic result: case report.
Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Anus Neoplasms; Carcinoma; Child; Combined Modality Therapy; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; Humans; Imiquimod; Immunocompromised Host; Low-Level Light Therapy; Papillomavirus Infections; Risk Assessment; Treatment Outcome; Vulvar Neoplasms | 2005 |
[Imiquimod--a substance with a broad working spectrum].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Dermatologic Agents; Focal Epithelial Hyperplasia; Imiquimod; Papillomavirus Infections; Skin Neoplasms | 2004 |
A tale of three Hs: HPV, HIV & HAART.
Topics: Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Female; HIV Infections; Humans; Imiquimod; Male; Mass Screening; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Viral Vaccines | 2006 |
Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Biopsy; Diagnosis, Differential; DNA, Viral; Female; Follow-Up Studies; Humans; Imiquimod; Kidney Transplantation; Male; Middle Aged; Ointments; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Porokeratosis | 2006 |
[Assessment of the treatment with imiquimod in persistent infection by human papillomavirus with the polimerase chain reaction method].
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Uterine Cervical Neoplasms | 2006 |
Human papillomavirus type 5 infection in a patient with Hailey-Hailey disease successfully treated with imiquimod.
Topics: Aminoquinolines; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Opportunistic Infections; Papillomaviridae; Papillomavirus Infections; Pemphigus, Benign Familial; Scrotum | 2007 |
HPV-related vulvar intraepithelial neoplasia: outcome of different management modalities.
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma in Situ; Catheter Ablation; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Middle Aged; Papillomavirus Infections; Precancerous Conditions; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2007 |
p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load.
Topics: Administration, Cutaneous; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Biomarkers, Tumor; Carcinoma in Situ; Cyclin-Dependent Kinase Inhibitor p16; DNA, Viral; Homosexuality, Male; Humans; Imiquimod; Ki-67 Antigen; Male; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Precancerous Conditions; Viral Load | 2007 |
Imiquimod treatment of papilloma virus and DMBA /TPA-induced cutaneous skin cancer in Mastomys coucha: an unique animal model system useful for preclinical studies.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Imiquimod; Murinae; Papilloma; Papillomavirus Infections; Skin Neoplasms; Tetradecanoylphorbol Acetate; Treatment Outcome | 2007 |
Successful treatment of extensive human papillomavirus-associated oral leucoplakia with imiquimod.
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Female; Humans; Imiquimod; Leukoplakia, Oral; Middle Aged; Papillomavirus Infections; Secondary Prevention; Treatment Outcome | 2008 |
[Treatment of pediatric genital condyloma].
Topics: Adult; Aminoquinolines; Antiviral Agents; Child; Cidofovir; Condylomata Acuminata; Cytosine; Humans; Imiquimod; Interferon Inducers; Keratinocytes; Organophosphonates; Papillomaviridae; Papillomavirus Infections | 2008 |
Changes in strategies for human papillomavirus genital disease.
Topics: Aminoquinolines; Colposcopy; DNA, Viral; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Papillomavirus Infections; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1997 |
Detection of human papillomavirus and response to topical 5% imiquimod in a case of stucco keratosis.
Topics: Aged; Aminoquinolines; DNA, Viral; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Molecular Sequence Data; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Tumor Virus Infections | 2000 |
[Imiquimod: a new treatment possibility in bowenoid papulosis?].
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Biopsy; Bowen's Disease; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Ointments; Papillomaviridae; Papillomavirus Infections; Penile Diseases; Risk Factors; Sexual Partners; Sexually Transmitted Diseases, Viral; Skin; Skin Diseases, Papulosquamous; Skin Neoplasms; Time Factors; Tumor Virus Infections | 2001 |
Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Follow-Up Studies; Humans; Imiquimod; Immunity, Innate; Keloid; Molluscum Contagiosum; Molluscum contagiosum virus; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Recurrence; Warts | 2002 |
Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Immunity, Cellular; Immunity, Innate; Interferon Inducers; Keratosis; Papillomaviridae; Papillomavirus Infections | 2002 |